Position in TGTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$962,603
+$380,556 QoQ
Shares Held
17,521
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 30 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $3,313,596 across 9 Biotechnology names. TGTX ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
This page
|
17,521 | $962,603 | |
| 2 | EXEL |
Exelixis, Inc.
|
16,029 | $872,137 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
11,032 | $863,474 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
500 | $248,365 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
6,000 | $220,800 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
22,607 | $94,045 | |
| 7 | BDTX |
Black Diamond Therapeutics, Inc.
|
13,484 | $24,945 | |
| 8 | GUTS |
Fractyl Health, Inc.
|
21,272 | $16,889 |
All Filings in TGTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $962,603 | 17,521 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $582,047 | 17,521 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $522,301 | 17,521 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $632,946 | 17,521 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $630,580 | 17,521 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $694,283 | 17,608 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $527,382 | 17,521 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $395,220 | 16,897 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $300,597 | 16,897 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $256,547 | 16,867 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $288,088 | 16,867 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $146,759 | 17,555 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $425,235 | 17,119 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $257,469 | 17,119 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $167,986 | 14,200 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $69,412 | 11,725 | Shares | Sole | 2022-10-14 | |
| No filing history on record for this holder in this stock. | ||||||